Bruker Corp BRKR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
-
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry
-
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology
-
Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI
-
Bruker Reports First Quarter 2026 Financial Results
-
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
-
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
-
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
Trading Information
- Previous Close Price
- $55.80
- Day Range
- $54.41–56.30
- 52-Week Range
- $28.53–64.54
- Bid/Ask
- $51.90 / $55.30
- Shares Outstanding
- 152.23M
- Market Cap
- $8.33B
- Volume/Avg
- 906 / 2M
Key Statistics
- Price/Earnings (Normalized)
- 32.47
- Price/Sales
- 2.38
- Dividend Yield (Trailing)
- 0.37%
- Dividend Yield (Forward)
- 0.37%
- Total Yield
- 0.37%
Company Profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 11,085
- Website
- https://www.bruker.com
Valuation
|
Metric
|
BRKR
|
|---|---|
Price/Earnings (Normalized) | 32.47 |
Price/Book Value | 3.37 |
Price/Sales | 2.38 |
Price/Cash Flow | 25.87 |
Price/Earnings
BRKR
Financial Strength
|
Metric
|
BRKR
|
|---|---|
Quick Ratio | 0.65 |
Current Ratio | 1.55 |
Interest Coverage | 0.98 |
Quick Ratio
BRKR
Profitability
|
Metric
|
BRKR
|
|---|---|
Return on Assets (Normalized) | 4.27% |
Return on Equity (Normalized) | 12.10% |
Return on Invested Capital (Normalized) | 6.90% |
Return on Assets
BRKR
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Scdzdln | Hfwgnn | $154B | |||
| Stryker Corp
SYK
| Hxzfpgxt | Zlcm | $115B | |||
| Medtronic PLC
MDT
| Btwdqtyg | Nkzwb | $100B | |||
| Boston Scientific Corp
BSX
| Grwhxfb | Jzbjc | $67B | |||
| Edwards Lifesciences Corp
EW
| Vyyrrhbvm | Kvdxng | $50B | |||
| Siemens Healthineers AG ADR
SMMNY
| — | Yrps | $45B | |||
| Siemens Healthineers AG Registered Shares
SEMHF
| — | Blsp | $45B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Pjdtqwdpc | Tjyk | $28B | |||
| DexCom Inc
DXCM
| Fdcksxywr | Nxxgvs | $27B | |||
| Koninklijke Philips NV
RYLPF
| Tsspbrtk | Lvjd | $26B |
United States